Libbe Englander is the CEO and Founder of Pharm3r, a healthcare analytics company established in October 2011 that focuses on enhancing client outcomes through the analysis of medical products and services. In addition to current roles at Pharm3r and as a member of the Robertson Therapeutic Development Fund Review Committee at Rockefeller University, Libbe has held significant positions in the healthcare sector including Principal at CCHScience, Managing Partner at NextStep Capital, and Founder and Portfolio Manager at BioPharma Capital. Libbe holds a Ph.D. in Molecular Biology from The Rockefeller University and a B.S. in Biology from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices